Monogram Orthopaedics (MGRM) Competitors $2.58 +0.07 (+2.79%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends MGRM vs. ZIMV, NPCE, RCEL, CVRX, SMTI, ZYXI, LUNG, ELMD, CATX, and PROFShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include ZimVie (ZIMV), NeuroPace (NPCE), AVITA Medical (RCEL), CVRx (CVRX), Sanara MedTech (SMTI), Zynex (ZYXI), Pulmonx (LUNG), Electromed (ELMD), Perspective Therapeutics (CATX), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. ZimVie NeuroPace AVITA Medical CVRx Sanara MedTech Zynex Pulmonx Electromed Perspective Therapeutics Profound Medical Monogram Orthopaedics (NASDAQ:MGRM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Does the media favor MGRM or ZIMV? In the previous week, Monogram Orthopaedics had 5 more articles in the media than ZimVie. MarketBeat recorded 5 mentions for Monogram Orthopaedics and 0 mentions for ZimVie. Monogram Orthopaedics' average media sentiment score of 0.36 beat ZimVie's score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the media. Company Overall Sentiment Monogram Orthopaedics Neutral ZimVie Neutral Do analysts recommend MGRM or ZIMV? Monogram Orthopaedics presently has a consensus target price of $4.00, indicating a potential upside of 55.04%. ZimVie has a consensus target price of $19.50, indicating a potential upside of 43.38%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, research analysts plainly believe Monogram Orthopaedics is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50ZimVie 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is MGRM or ZIMV more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to ZimVie's net margin of -77.31%. ZimVie's return on equity of 2.90% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Monogram OrthopaedicsN/A -130.90% -106.38% ZimVie -77.31%2.90%1.17% Do insiders & institutionals believe in MGRM or ZIMV? 0.4% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 28.1% of Monogram Orthopaedics shares are held by company insiders. Comparatively, 3.0% of ZimVie shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer MGRM or ZIMV? ZimVie received 1 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 100.00% of users gave Monogram Orthopaedics an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformMonogram OrthopaedicsOutperform Votes2100.00% Underperform VotesNo VotesZimVieOutperform Votes318.75%Underperform Votes1381.25% Which has better earnings & valuation, MGRM or ZIMV? Monogram Orthopaedics has higher earnings, but lower revenue than ZimVie. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than ZimVie, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMonogram Orthopaedics$365.00K242.53-$13.74M-$0.47-5.49ZimVie$451.29M0.83-$393.28M-$13.11-1.04 Which has more risk & volatility, MGRM or ZIMV? Monogram Orthopaedics has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.12, suggesting that its stock price is 112% more volatile than the S&P 500. SummaryMonogram Orthopaedics beats ZimVie on 11 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.53M$4.34B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E Ratio-5.4925.3791.3417.19Price / Sales242.5345.681,116.59116.80Price / CashN/A43.4542.6437.86Price / Book6.007.364.794.78Net Income-$13.74M$13.64M$120.07M$225.60M7 Day Performance-3.01%-2.80%-1.89%-1.24%1 Month Performance30.30%0.56%11.45%3.36%1 Year Performance-23.10%41.87%30.61%16.58% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics3.2328 of 5 stars$2.58+2.8%$4.00+55.0%-24.1%$88.53M$364,999.00-5.4928Gap DownZIMVZimVie2.3679 of 5 stars$13.69-0.3%$18.33+33.9%-20.6%$377.84M$457.43M-1.052,600NPCENeuroPace3.7644 of 5 stars$11.17+1.3%$14.60+30.7%+24.4%$333.40M$76.45M-11.03170Analyst ForecastPositive NewsRCELAVITA Medical1.6504 of 5 stars$12.47+2.1%$16.50+32.3%-5.3%$326.96M$50.14M-5.48130News CoveragePositive NewsCVRXCVRx3.7816 of 5 stars$13.21+3.0%$16.67+26.2%-49.2%$320.53M$47.26M-4.75200Positive NewsSMTISanara MedTech1.9969 of 5 stars$33.73-2.7%$44.00+30.4%-14.5%$294.80M$64.99M-35.0060ZYXIZynex3.4977 of 5 stars$8.43+3.6%$14.00+66.1%-21.1%$268.50M$184.32M54.271,100Positive NewsLUNGPulmonx2.6733 of 5 stars$6.11+0.2%$12.75+108.7%-49.2%$241.27M$79.30M-4.15250ELMDElectromedN/A$28.36+0.6%N/A+158.0%$239.87M$57.06M39.14174CATXPerspective Therapeutics3.3599 of 5 stars$3.42-1.7%$15.14+342.8%N/A$231.15M$1.43M0.00116Positive NewsPROFProfound Medical2.5391 of 5 stars$7.26-1.9%$13.75+89.4%-12.8%$218.02M$7.20M-5.52150High Trading Volume Related Companies and Tools Related Companies ZimVie Competitors NeuroPace Competitors AVITA Medical Competitors CVRx Competitors Sanara MedTech Competitors Zynex Competitors Pulmonx Competitors Electromed Competitors Perspective Therapeutics Competitors Profound Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MGRM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
